Synthetic biology and precision medicine in blood and gynaecological cancers
Synthetic biology and precision medicine in blood and gynaecological cancers
The future of Choosing Wisely Africa
The rules of grant writing
Zanidatamab, palbociclib and fulvestrant show positive results in treating HER2+/HR+ mBC
Toripalimab and metronomic chemotherapy show efficacy in treating in HER2-negative metastatic breast cancer
Adding nivolumab to R-GemOx shows enhanced efficacy in treating R/R large B-cell lymphoma
Beat AML master trial: A clinical trial for acute myeloid leukaemia
BrECADD combined with PET2-guided treatment sets a new benchmark for the treatment of newly diagnosed advanced-stage cHL
Ponatinib is superior to imatinib in combination with chemotherapy for newly diagnosed Ph+ ALL
SABCS 2023: Latest breast cancer diagnostics guidelines
The evolving paradigm in management of Multiple Myeloma
Introducing oncology to undergraduate medical and allied health sciences students